These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 6327987)

  • 1. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
    Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
    J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D; Delisle-Mizon F; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.
    Chen HY; Yuan M; Livermore DM
    J Med Microbiol; 1995 Oct; 43(4):300-9. PubMed ID: 7562993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
    Chau PY; Ling J; Ng WS
    J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant strains of Pseudomonas aeruginosa isolated after exposure to several beta-lactam antibiotics.
    Hoekstra JL; de Neeling AJ; van Klingeren V; Stobberingh EE; van Boven CP
    Eur J Clin Microbiol; 1987 Feb; 6(1):22-7. PubMed ID: 3106033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():163-7. PubMed ID: 19802980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.
    Gargalianos P; Oppenheim BA; Skepastianos P; Livermore DM; Williams RJ
    J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National survey of antibiotic resistance in Pseudomonas aeruginosa.
    Williams RJ; Lindridge MA; Said AA; Livermore DM; Williams JD
    J Antimicrob Chemother; 1984 Jul; 14(1):9-16. PubMed ID: 6434505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of azlocillin resistance in Pseudomonas aeruginosa].
    Labia R; Morand A; Ben Yaghlane H
    Presse Med; 1984 Mar; 13(13):777-9. PubMed ID: 6231594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS; Neu HC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
    Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C
    Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro activity of beta-lactam antibiotics against gentamicin and/or carbenicillin-resistant Pseudomonas aeruginosa strains.
    Aisa ML; Omenaca M; Bergua C; Garcia-Moya JB
    Infection; 1982; 10 Suppl 3():S244-8. PubMed ID: 6818157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative effect of beta-lactam activity on Pseudomonas aeruginosa as a function of resistance phenotypes].
    Thabaut A; Philippon A; Meyran M
    Presse Med; 1984 Mar; 13(13):768-71. PubMed ID: 6231592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity and beta-lactamase stability of carbenicillin, ticarcillin, azlocillin, mezlocillin and cefotaxime.
    Tselentis J; Cordossis T; Kosmidis J; Lambropoulos S; Melissinos K
    J Antimicrob Chemother; 1981 Oct; 8(4):317-21. PubMed ID: 6271725
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.
    Livermore DM; Yang YJ
    J Infect Dis; 1987 Apr; 155(4):775-82. PubMed ID: 3102630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The patterns and transmissibility of antibiotic resistance among clinical strains of Pseudomonas aeruginosa.
    Palillo ES; Salleh MA
    Microbiol Immunol; 1992; 36(11):1195-200. PubMed ID: 1491621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
    Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
    Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
    Sofianou DC; Douboyas JP
    J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.